MLTX: Announces $150M Share Offering
MoonLake Immunotherapeutics announces proposed public offering of $150M of its Class A ordinary shares
MoonLake Immunotherapeutics Announces Proposed Public Offering Of $150M Of Its Class A Ordinary Shares
MoonLake Immunotherapeutics announces proposed public offering of $150M of its Class A ordinary shares
MoonLake Immunotherapeutics Announces Proposed Public Offering Of $150M Of Its Class A Ordinary Shares